Donald E. White
Impact in
- Immunology top 0.02%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Oncology top 0.02%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 41
- CAR-T cell therapy research 19
- Cancer Immunotherapy and Biomarkers 16
- Immunology 26
- Immunotherapy and Immune Responses 22
- Co-authors
- Steven A. Rosenberg (74 shared papers)James Chih‐Hsin Yang (33 shared papers)Claudia A. Seipp (20 shared papers)Suzanne L. Topalian (25 shared papers)Douglas J. Schwartzentruber (26 shared papers)Richard M. Sherry (29 shared papers)Mark E. Dudley (13 shared papers)John R. Wunderlich (16 shared papers)
- Journals
- Journal of Immunotherapy (16 papers)Journal of Clinical Oncology (16 papers)Clinical Cancer Research (10 papers)Cancer (8 papers)Geological Society of America Bulletin (7 papers)
- Partner nations
- United StatesMalaysiaAustralia
In The Last Decade
Donald E. White
157 papers receiving 26.9k citations
Donald E. White's Hit Papers
Peers
Comparison fields: 5 of 183
- Immunology 14.3k
- Oncology 15.4k
- Geochemistry and Petrology 985
- Geophysics 1.4k
- Genetics 2.8k
Countries citing papers authored by Donald E. White
This map shows the geographic impact of Donald E. White's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald E. White with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald E. White more than expected).
Fields of papers citing papers by Donald E. White
This network shows the impact of papers produced by Donald E. White. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald E. White. The network helps show where Donald E. White may publish in the future.
Co-authors
The 25 scholars most cited alongside Donald E. White, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 162 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone Hit paper breakdown → | 1987 | 2351 |
| 2 | Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes Hit paper breakdown → | 2002 | 2268 |
| 3 | Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma Hit paper breakdown → | 1988 | 1906 |
| 4 | Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy Hit paper breakdown → | 2011 | 1669 |
| 5 | Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma Hit paper breakdown → | 1998 | 1532 |
| 6 | Tumor antigen–specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired Hit paper breakdown → | 2009 | 1443 |
| 7 | Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens Hit paper breakdown → | 2008 | 1066 |
| 8 | A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer Hit paper breakdown → | 2006 | 1032 |
| 9 | Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer Patients Hit paper breakdown → | 1989 | 848 |
| 10 | Treatment of Patients With Metastatic Melanoma With Autologous Tumor-Infiltrating Lymphocytes and Interleukin 2 Hit paper breakdown → | 1994 | 828 |
| 11 | Randomized Study of High-Dose and Low-Dose Interleukin-2 in Patients With Metastatic Renal Cancer Hit paper breakdown → | 2003 | 603 |
| 12 | Ipilimumab (Anti-CTLA4 Antibody) Causes Regression of Metastatic Renal Cell Cancer Associated With Enteritis and Hypophysitis Hit paper breakdown → | 2007 | 572 |
| 13 | Prognostic Factors Related to Clinical Response in Patients with Metastatic Melanoma Treated by CTL-Associated Antigen-4 Blockade Hit paper breakdown → | 2007 | 538 |
| 14 | 1998 | 407 | |
| 15 | CTLA-4 Blockade with Ipilimumab: Long-term Follow-up of 177 Patients with Metastatic Melanoma Hit paper breakdown → | 2012 | 383 |
| 16 | 2005 | 380 | |
| 17 | 2004 | 363 | |
| 18 | 1989 | 317 | |
| 19 | 1957 | 296 | |
| 20 | 2002 | 290 |
About Donald E. White
Donald E. White is a scholar working on Oncology, Immunology, Mechanics of Materials, Artificial Intelligence and Pulmonary and Respiratory Medicine, having authored 162 papers that have together received 28.7k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (22 papers), Hydrocarbon exploration and reservoir analysis (21 papers), CAR-T cell therapy research (19 papers), Geochemistry and Geologic Mapping (17 papers), Cancer Immunotherapy and Biomarkers (16 papers), Geology and Paleoclimatology Research (9 papers), Geological Studies and Exploration (9 papers) and Geological and Geochemical Analysis (9 papers). The work is most often cited by research in Immunology (14.3k citations), Oncology (15.4k citations), Geochemistry and Petrology (985 citations), Geophysics (1.4k citations) and Genetics (2.8k citations). Donald E. White has collaborated with scholars based in United States, Malaysia and Australia. Frequent co-authors include Steven A. Rosenberg, James Chih‐Hsin Yang, Claudia A. Seipp, Suzanne L. Topalian, Douglas J. Schwartzentruber, Richard M. Sherry, Mark E. Dudley, John R. Wunderlich, Seth M. Steinberg and Nicholas P. Restifo. Their work appears in journals such as Journal of Immunotherapy, Journal of Clinical Oncology, Clinical Cancer Research, Cancer and Geological Society of America Bulletin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.